Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetri...(ream. JAS which was acquired by Escalon...),Health

Date:7/30/2008

ream." JAS, which was acquired by Escalon in May 2008, plans to submit chemistry panels for FDA Clinical Laboratory Improvement Amendment ("CLIA") classification, necessary in order to for moderately-complex laboratories to use the analyzer, and anticipates the classifications to be obtained over the next several months.

Richard J. DePiano Sr., Chairman and Chief Executive Officer added, "We are pleased to announce this FDA clearance, which not only illustrates the strategic value of our recent acquisition of JAS Diagnostic but also our ability to expand our position in the clinical chemistry market. We remain committed to meeting the needs of the clinical community and delivering innovative and cost-effective technologies."

JAS is a manufacturer of class I and II in vitro diagnostics ("IVD") reagents that markets its products to physician, reference, hospital and veterinary laboratories throughout the world.

Founded in 1987, Escalon (http://www.escalonmed.com) develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew Scientific, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology, as well as veterinary hematology and blood chemistry. Escalon seeks to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of Escalon's distribution capabilities, although such partnerships or acquisitions may not occur. Escalon has headquarters in Wayne, Pennsylvania and manufacturing operations in Long Island, New York, New Berlin, Wisconsin, Dallas, Texas, Waterbury, Connecticut, Miami, Florida, and Barrow-in-Furness, U.K.

Note: This
'/>"/>

SOURCE Escalon Medical Corp. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
2. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
3. Escalon(R) Announces Executive Promotions
4. Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System
5. Escalon(R) Reports First Quarter Fiscal 2008 Results
6. Escalon(R) Reports Financial Results for 2007 Fiscal Year
7. French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia
8. Pandemic research receives $1.6M funding boost
9. Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi
10. Greater Medical Center Group Receives Major Funding From MELCO Investments
11. NJHA Receives Planning Grant from RWJF for Regional Market Quality Project